Eiger BioPharmaceuticals 2017-06-30T18:30:18+00:00

IN THE NEWS
1311, 2017

Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference

Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference PALO ALTO, Calif. – November 13, 2017 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for orphan diseases, announced today that David Cory, President and CEO of Eiger, will present a corporate update at Jefferies 2017 Healthcare Conference on Thursday, November 16, 2017 at 4:40 pm CET at the Waldorf Hilton London in the Westminster Room on the Entresol Level.  Eiger will also host one-on-one meetings. [...]

911, 2017

Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results

Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results Clinical Results Planned in Each of Four Orphan Disease Programs by 4Q 2018 Cash Runway Extends Through Mid-2019 PALO ALTO, Calif., November 9, 2017 — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today financial results for the three months and nine months ended September 30, 2017 and provided a business update. “Eiger is well positioned to deliver regulatory and clinical results [...]

611, 2017

Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences

Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences PALO ALTO, Calif. – November 6, 2017 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for orphan diseases, announced today that David Cory, President and CEO of Eiger, will participate and present in three upcoming investor conferences. Jefferies 2017 London Healthcare Conference, November 15-16, 2017 at Waldorf Hilton London. Eiger will host one-on-one meetings. 29th Annual Piper Jaffray Healthcare Conference, November 29, 2017,      Fireside Chat at 3:00 [...]